search icon

      Market Snapshot

      blog search icon

      AKRO Stocks Valuation and Technical Analysis

      Akero Therapeutics, Inc.



      -0.45 (-1.01%)

      At Close: 4:00 PM


      0.00 (0.00%)

      After Market: 12:35 AM

      AKRO Stock Performance Chart (1 Year)

      Akero Therapeutics, Inc.

      The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism.

      However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators.

      Comparing their expectations to the market could help investors estimate their prospective return.



      • 1 Week
      • 1 Month
      • Quarter
      • Half Year
      • 1 Year
      • YTD


      • N/A
      • N/A
      • N/A
      • N/A
      • N/A
      • N/A


      • N/A
      • N/A
      • N/A
      • N/A
      • N/A
      • N/A


      • -5.60%
      • 15.25%
      • 2.70%
      • 14.17%
      • 394.14%
      • -15.33%

      AKRO Fundamental Analysis

      • ATR2.24
      • Enterprise Value1.87B
      • Avg Vol (3 Months)645.07K
      • Avg Vol (10 Days)641.74K

      AKRO Stock Performance Chart (52 Weeks)

      • 52-Week High54.88
      • 52-Week Low7.52
      • 52-Week ChgN/A
      • S&P 500 52-Week ChgN/A

      AKRO Industry Analysis and Valuation


      • P/E (TTM)info icon
      • P/C (MRQ)info icon
      • P/S (TTM)info icon
      • P/B (MRQ)info icon


      • N/A
      • 6.47
      • N/A
      • 6.85

      Industry Avg

        Sector Median

          S&P 500

            AKRO Technical Analysis

            • SMA 203.02%
            • SMA 5010.82%
            • SMA 20023.52%
            • RSI (14)56.92

            Frequently Asked Questions


            How is AKRO price-to-earnings ratio currently?

            AKRO has a current P/E ratio of N/A.


            How are AKRO's price-to-sale and price-to-book ratios?

            The AKRO stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 6.85.


            Is Akero Therapeutics, Inc.'s price-to-cash ratio high or low?

            AKRO's price-to-cash (P/C) ratio is 6.47, an indicator that is currently being trending upward.


            What's current simple moving average (SMA) for AKRO?

            Based on AKRO's recent bid, its distance from 20 days simple moving average is 3.02%. It is 10.82% apart from 50 days simple moving average, and it is 23.52% apart from 200 days simple moving average.


            What is the 52-week price range for AKRO?

            The 52-week high for AKRO is $54.88 which is 0.18% away from the current price level whereas the distance of that from the 52-week low of $7.52 stands at 4.95%.


            An overview of AKRO's stock performance: how did it fare?

            The performance of AKRO stock was encouraging with all of its significant price indictors in green. Akero Therapeutics, Inc. (NASDAQ: AKRO) shares have moved downward -1.01% or -$0.45 in the latest trading session and have loss -15.33% year-to-date (YTD). The stock has gained nearly 394.14% over the past year. After moving 2.70% over the trailing 3-month period, the stock is 14.17% higher in the 6-month period. Looking at its performance over the shorter term, it's down -5.60% a week and 15.25% a month.


            What is AKRO's 14-day relative strength index (RSI)?

            The current 14-day RSI for AKRO stock is 56.92. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.


            For AKRO, what is the average true range (ATR) for the past two weeks?

            ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Akero Therapeutics, Inc. (AKRO) has a 14-day ATR of 2.24.


            What is AKRO's current enterprise value?

            After closing at $43.89 with 46.85 Million of its shares outstanding, the current enterprise value of AKRO is roughly 1.87 Billion.


            Over the past year, how has the stock price of AKRO changed?

            Akero Therapeutics, Inc. (NASDAQ: AKRO) is up N/A when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of N/A. AKRO stock price is also down -15.33% on its value in year-to-date trading.


            What is the average trading volume for AKRO shares?

            The number outstanding shares of AKRO is 46.85 Million, and of these 42.37 Million shares are freely available for trading. On average, AKRO stock has traded 641.74 Thousands shares per day for the past 10 days. A total of 267.12 Thousands shares changed hands during the last trading session with the average session volume of 645.07 Thousands shares.